The persistent NAV decline and heavy ATM dilution pressure the common equity. Monitor distribution coverage closely; if NAV continues to erode, the $0.035/month payout may face a cut. The heavy reliance on ATM issuance to fund operations suggests limited organic capital generation. Watch for further non-accrual migration in the CLO equity portfolio.
Price Chart
Executive Summary
Oxford Square Capital Corp. reported Q2 2026 results with total investment income of $9.4M (down ~1.3% YoY), net investment income of $5.1M (down ~6.6% YoY), and NAV per share declining to $1.29 from $1.69 at year-end 2025. The company continued aggressive ATM equity issuance, selling 11.3M shares for $17.8M net, while maintaining a $0.035/month distribution. Persistent NAV erosion, rising expense ratios, and shareholder dilution signal deteriorating fundamentals for this BDC.
Key Facts
- NAV per share fell to $1.29 as of June 30, 2026 from $1.32 on March 31 and $1.69 on December 31, 2025
- Net investment income Q2 2026: $5.1M vs $5.5M in Q2 2025 (-6.6% YoY)
- Total investment income Q2 2026: $9.4M vs $9.5M in Q2 2025 (-1.3% YoY)
- Issued ~11.3M shares via ATM in Q2 2026 for net proceeds of ~$17.8M; shares outstanding rose to 105.1M
- Total return based on market value was -19.75% in Q2 2026
- Weighted average shares outstanding Q2 2026: 99.3M vs 73.2M in Q2 2025 (+36%)
- Annualized expense ratio increased to 14.39% from 10.78% a year ago
- Preferred equity investments in one portfolio company on non-accrual, $6.9M fair value
- Monthly distributions maintained at $0.035 per share for Oct/Nov/Dec 2026
Financial Impact
Total investment income declined $0.12M YoY to $9.4M; NII declined $0.36M YoY to $5.1M; net assets fell $10.4M from Dec 2025 to $135.0M; market capitalization based on end-of-quarter price of $1.32 on 105.1M shares is approximately $138.7M, compared to ~$151.5M at the start of the quarter
Risk Factors
- Continuing NAV erosion could trigger asset coverage or debt covenant issues
- ATM dilution further depresses per-share metrics and market price
- Non-accrual CLO equity investments ($6.9M fair value) may expand
- Rising expense ratio (14.4% annualized) compresses returns to shareholders
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-084087 |
| Document: ea0300117-01_8k.htm | 0001213900-26-084087 |
| Document: 0001213900-26-084087-index-headers.html | 0001213900-26-084087 |
| Document: 0001213900-26-084087-index.html | 0001213900-26-084087 |
| Document: 0001213900-26-084087.txt | 0001213900-26-084087 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | Press Release | $1.18 | awaiting T+60 | — | $1.21 (+2.54%) |
Jul 31, 2026 12w ago | 8-K | $1.41 $1.22 | ▲ +13.40% | ▲ +15.18% | $1.21 (+14.07%) |
Jul 31, 2026 12w ago | 8-K | $1.55 $1.18 | ▲ +23.87% | ▲ +26.33% | $1.21 (+21.94%) |
Jul 31, 2026 12w ago | Press Release | $1.55 $1.18 | ▲ +23.87% | ▲ +26.33% | $1.21 (+21.94%) |
May 21, 2026 22w ago | Insider Cluster | $1.38 $1.42 | ▲ +2.90% | ▼ −1.40% | $1.21 (−12.32%) |
Apr 29, 2026 25w ago | Press Release | $1.59 $1.31 | ▲ +17.87% | ▲ +22.00% | $1.21 (+23.92%) |
Apr 22, 2026 26w ago | Press Release | $1.64 $1.36 | ▼ −17.08% | ▼ −22.97% | $1.21 (−26.32%) |
Mar 3, 2026 34w ago | Press Release | $1.75 $1.32 | ▲ +24.60% | ▲ +34.91% | $1.21 (+30.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers